YourRhythmics
PrivateLast Round
Seed
Jul 22, 2021
Total Funding Raised
$470,000
Company Overview
YourRhythmics is a diagnostic equipment company that develops a high-resolution ECG recorder and software to non-invasively determine the frequency and complexity dynamics of atrial fibrillation.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Healthcare Analytics, Medical AI, Precision Medicine, Sensors
Business Model
B2B
Customer Profile
Hardware + Subscription, Hardware Sales, Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
YourRhythmics Comparables
Compare YourRhythmics with similar companies based on industry and business-model similarity.
YourRhythmics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jul 22, 2021 |
Key People
Founding team and executive leadership
YourRhythmics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Maastricht University | Seed |
| Brightlands Venture Partners | Seed |
| UniVenture B.V. | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 22, 2021
$470K round led by Medlodi
YourRhythmics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about YourRhythmics's valuation, stock price, and market status.